• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Bacterial endotoxinemia and risk of hemorrhage from oesophageal varicose veins in patients with liver cirrhosis].

作者信息

Garbuzenko D V, Mikurov A A, Smirnov D M

出版信息

Klin Med (Mosk). 2012;90(7):48-51.

PMID:23019976
Abstract

This work was designed to substantiate the necessity of estimating serum bacterial endotoxin levels in patients with liver cirrhosis (LC) for the prognostication of the risk of bleeding from oesophageal varices. The prospective cohort study included 90 patients with LC and clinical signs of portal hypertension. Total endotoxin of Gram-negative bacteria was measured by the activated particle method. The intensity of endotoxemia was estimated using the end-point turbidimetric test (variant of LAL test). Pronounced endotoxemia was associated with acute bleeding from oesophageal varices. Its severity in the patients with the history of hemorrhage was higher than in the absence of this complication. The endotoxin level in the range from 0 to 4 ng/ml suggested low probability of hemorrhage; its risk increased significantly at the endotoxin level in excess of 4.1 ng/ ml. It is concluded that the severity of endotoxemia in LC patients correlates with the degree of oesophageal vein dilation and hemorrhage, the endotoxin level of 4 ng/ml being a reliable diagnostic criterion for the associated risks.

摘要

相似文献

1
[Bacterial endotoxinemia and risk of hemorrhage from oesophageal varicose veins in patients with liver cirrhosis].
Klin Med (Mosk). 2012;90(7):48-51.
2
Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.门静脉高压综合征儿童及青少年食管静脉曲张的临床及实验室预测指标
J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):178-83. doi: 10.1097/MPG.0b013e318156ff07.
3
[Bacterial infection and its relation to the genesis and course of varicose hemorrhage].
Vnitr Lek. 2007 Dec;53(12):1255-64.
4
[Factors participating in development of bleeding varices in portal hypertension. Part I: bacterial infection and comparison of intravenous and peroral antibiotics effects--a randomised study].
Vnitr Lek. 2004 Nov;50(11):830-5.
5
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.一组肝硬化和食管静脉曲张患者的长期发病率和死亡率。
Hepatogastroenterology. 1995 Nov-Dec;42(6):979-84.
6
Endoscopic sclerotherapy of oesophageal varices. A clinical study.食管静脉曲张的内镜硬化治疗。一项临床研究。
Acta Chir Scand Suppl. 1985;524:1-86.
7
[Endotoxinemia in liver cirrhosis].[肝硬化中的内毒素血症]
Z Gastroenterol. 1976 Jan;14(1):14-23.
8
Portal hypertensive hemorrhage: pathogenesis and risk factors.门静脉高压性出血:发病机制与危险因素
Semin Gastrointest Dis. 1995 Jul;6(3):125-33.
9
Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.肝硬化合并食管静脉曲张患者首次静脉曲张出血的预测。一项前瞻性多中心研究。
N Engl J Med. 1988 Oct 13;319(15):983-9. doi: 10.1056/NEJM198810133191505.
10
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices.肝脏硬度测量可筛选出有患大食管静脉曲张风险的肝硬化患者。
J Hepatol. 2006 Aug;45(2):230-5. doi: 10.1016/j.jhep.2006.04.006. Epub 2006 May 16.

引用本文的文献

1
Current approaches to the management of patients with cirrhotic ascites.当前肝硬化腹水患者管理方法。
World J Gastroenterol. 2019 Jul 28;25(28):3738-3752. doi: 10.3748/wjg.v25.i28.3738.
2
Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.肝硬化门静脉高压症医学治疗的当代概念
World J Gastroenterol. 2015 May 28;21(20):6117-26. doi: 10.3748/wjg.v21.i20.6117.
3
Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis.黄芩素通过减少肠黏膜细胞凋亡降低肝硬化内毒素血症的发生。
BMC Complement Altern Med. 2015 May 29;15:161. doi: 10.1186/s12906-015-0682-8.